The positive correlation between drug addiction and drug dosage in vemurafenib-resistant melanoma cells is underpinned by activation of ERK1/2-FRA-1 pathway.

Malignant melanoma is a kind of highly invasive and deadly diseases. The BRAF inhibitor (BRAFi) such as vemurafenib could achieve a high response rate in melanoma patients with BRAF mutation. However, melanoma cells could easily develop resistance as well as addiction to BRAFi. Based on the drug addiction, intermittent treatment has been proposed to select against BRAFi-resistant melanoma cells. Because different dosages of BRAFi might be used in patients, it is necessary to know about the relationship between drug dosage and the degree of addiction. To address the problem, four drug-resistant melanoma cell sublines (A375/R0.5, A375/R2.0, M14/R0.5 and M14/R2.0) were established by continuously exposure of melanoma A375 or M14 cells to 0.5 or 2.0 µM vemurafenib. Vemurafenib withdrawal resulted in much stronger suppression on clone formation in A375/R2.0 and M14/R2.0, compared with A375/R0.5 and M14/R0.5, respectively. Meanwhile, stronger upregulation of ERK1/2-FRA-1 pathway could be observed in A375/R2.0 and M14/R2.0. Further detection showed that some proinflammatory cytokines downstream of ERK1/2-FRA-1 pathway were upregulated after drug withdrawal, and the conditioned medium collected from the resistant A375 cells could inhibit clone formation. Furthermore, vemurafenib withdrawal resulted in suppressed cell proliferation rather than cell senescence, with stronger effect on A375/R2.0 compared with A375/R0.5. This study suggested that the depth of vemurafenib addiction in resistant melanoma cells is positively correlated to the drug dosage, which might be underpinned by the ERK1/2-FRA-1 pathway and the related cytokines.

Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.

Although targeted therapy and immunotherapy greatly improve the outcome of melanoma, drug resistance and low response rates still maintain the unsubstitutability of traditional chemotherapy. Cisplatin (CDDP) is widely used in different types of tumours with high response rates, but it generally has low efficiency in melanoma. The mechanisms underpinning the phenomena are not sufficiently understood. Here we demonstrated that various melanoma cell lines adopted senescence phenotype after CDDP treatment in contrast to the other types of tumour cells. CDDP treatment induced melanoma A375 cells into senescence through the sequential activation of the DNA damage response and the P53/P21 pathway. All the senescent melanoma cells induced by CDDP alone or the combination of CDDP and dacarbazine developed robust senescence-associated secretory phenotype (SASP), that is, the secretion of multiple cytokines. IL-1α was an early component and an upstream regulator of SASP. Similarly, CDDP either alone or combined with dacarbazine could induce melanoma cell senescence and SASP in either A375 or B16F10 melanoma xenograft mice. The supernatant of senescent A375 cells promoted the growth of normal non-senescent A375 cells and enhanced their expression and secretion of IL-8 through the activation of the ERK1/2-RSK1 pathway. The transplantation of non-senescent and senescent A375 cells together into nude mice showed accelerated tumour growth compared with transplanting non-senescent cells alone; no tumours developed when transplanting senescent cells alone. Following CDDP administration in A375-bearing mice, the intratumour injection of neutralisation antibodies targeting the SASP factors IL-1α or IL-8 evidently delayed tumour growth. The results suggest that the CDDP-induced senescent melanoma cells promote non-senescent cells proliferation through the activation of ERK1/2-RSK1 pathway by the SASP factors. Cell senescence and concomitant SASP may be the particular mechanisms for melanoma to resist chemotherapeutics.

IL-1α inhibits proliferation and adipogenic differentiation of human adipose-derived mesenchymal stem cells through NF-κB- and ERK1/2-mediated proinflammatory cytokines.

Dysfunctional adipogenesis such as subcutaneous lipoatrophy is closely related to insulin resistance and metabolic disorders. Although the expression or release of the cytokine interleukin-1α (IL-1α) is known to increase in adipose tissue in response to cell death, cell senescence, aging, or solar radiation, the regulatory role of IL-1α in adipogenesis has not been sufficiently investigated. To investigate the problem, we explored the effect of IL-1α on the proliferation and adipogenic differentiation of human adipose-derived mesenchymal stem cells (ADSCs) using cell counting, alamarBlue assay, oil red O staining, Western blot, among others. The results showed that IL-1α evidently inhibited the proliferation and adipogenic differentiation of ADSCs, which might be related with the activated nuclear factor-κB (NF-κB) and extracellular signal-regulated kinase (ERK) 1/2 pathways. Early-stage adipogenic differentiation was more sensitive to IL-1α than late-stage differentiation. After differentiation of ADSCs into mature adipocytes, adding of IL-1α had no obvious influence on the cellular morphology, including lipid droplet accumulation. IL-1α enhanced the expression of proinflammatory cytokines, such as IL-8, IL-6, CCL2 (C-C motif chemokine ligand 2), and IL-1ß, when added into the adipogenic medium of ADSCs. Blocking IL-8 and IL-6 with neutralizing antibodies partially alleviated the inhibitory effect of IL-1α on the proliferation and adipogenic differentiation. The results suggest that IL-1α inhibits adipogenesis through activation of NF-κB and ERK1/2 pathways and subsequent upregulation of proinflammatory cytokines in ADSCs. IL-1α might play an important role in mediating lipoatrophy by regulation of ADSCs.

Multipetal-Structured and Dumbbell-Structured Gold-Polymer Composite Particles with Self-Modulated Catalytic Activity.

A simple synthesis route for gold-polymer composite particles with controlled structure (multipetal structure and dumbbell structure) is developed. It is intriguing to observe that by controlling the reaction time and size of gold nanoparticles (AuNPs), tetrapetal-, tripetal-, and dumbbell-structured gold-polystyrene composite are obtained via seeded polymerization. The average number of petals on a single AuNP increases with the AuNP diameter. These particles show potential applications as building blocks for advanced ordered and hierarchical supracolloidal materials. Further, with the incorporation of poly(N-isopropylacrylamide) (PNIPAm), "smart" thermoresponsive dumbbell-structured gold-PNIPAm/polystyrene composite particles are formed. Significant size variation is validated for particles with 83 and 91 wt % PNIPAm content around lower critical solution temperature (LCST), which results in self-modulated catalytic activity.

Thermo-responsiveness and tunable optical properties of asymmetric polystyrene/PNIPAM-gold composite particles.

Environmentally responsive polystyrene/poly (N-isopropylacrylamide)-gold composite particles are successfully synthesized via a Pickering emulsion polymerization method. It is found that the core-shell and asymmetric structured particles are simultaneously formed during the polymerization. Compared with the core-shell structured composite particles, the asymmetric particles have a higher thermo-responsiveness as a result of differences in morphology and formation mechanism. For asymmetric composite particles, an increase in N-isopropylacrylamide (NIPAAM) content leads to more significant size variation upon temperature changes. From rheology measurements, the viscosity of asymmetric particles suspension greatly decreases as temperature is increased above the lower critical solution temperature (LCST). The large size decrease in asymmetric composite particles gives rise to a significant scattering intensity increase, as a result of increased refractive index contrast between the PNIPAM content and surrounding water. The resulting size decrease also leads to tunable surface plasmon resonance properties.

Core-shell and asymmetric polystyrene-gold composite particles via one-step Pickering emulsion polymerization.

Core-shell structured polystyrene-gold composite particles are synthesized from one-step Pickering emulsion polymerization. The surface coverage of the core-shell composite particles is improved with increasing gold nanoparticle (AuNP) hydrophobicity and concentration. At high surface coverage, the AuNPs exhibit an ordered hexagonal pattern, likely due to electrostatic repulsion during the emulsion polymerization process. In addition to core-shell structured polystyrene-gold composite particles, an intriguing observation is that at low AuNP concentrations, asymmetric polystyrene-gold nanocomposite particles are simultaneously formed, where a single gold nanoparticle is attached onto each polystyrene particle. It is found that these asymmetric particles are formed via a "seeded-growth" mechanism. The core-shell and asymmetric polystyrene-gold composite particles prove to be efficient catalysts as they successfully catalyze the Rhodamine B reduction reaction with stable performance and show high recyclability as catalysts.